How insulin resistance and type 2 diabetes damage the brain across decades, and why the trials that lowered blood glucose did not improve cognition, is covered in full separately and not re-tread here. Why you feel flat at three in the afternoon is a different article again. This one is about obesity, one of the fourteen risk factors named by the Lancet Commission, and about a single word: when. Get the timing wrong and this literature appears to say the exact opposite of what it says — which is how it is usually reported.
The result that looks like it runs the wrong way
Start with the study that caused the trouble. Qizilbash and colleagues' 2015 cohort of 1,958,191 UK primary-care patients aged 40 and over had a median baseline age of 55, median 9.1 years of follow-up, and 45,507 dementia diagnoses. People with a BMI under 20 had roughly a third higher risk than the healthy-weight group. People with a BMI above 40 had a 29% lower risk (95% CI 22–36). The authors' interpretation was blunt — their results contradicted the hypothesis that midlife obesity raises dementia risk in old age.
Now the cohorts that started earlier. Whitmer and colleagues measured 10,276 Kaiser Permanente members aged 40 to 45 between 1964 and 1973, then counted dementia from 1994 to 2003: 713 cases. A BMI of 30 or above gave a hazard ratio of 1.74 (95% CI 1.34–2.26) and overweight 1.35 (1.14–1.60), adjusted for diabetes, hypertension, lipids and vascular disease. Meta-analyses agree on direction and differ on size: a 2011 pooling of 15 prospective studies put midlife obesity at 2.04 (1.59–2.62) for Alzheimer's disease and found late-life BMI not associated at all; a 2017 meta-regression of 589,649 people gave 1.33 (1.08–1.63), nothing for overweight, and noted publication and selection bias partly explaining the spread.
Two bodies of evidence, opposite signs. Neither is fraudulent.
What resolves it
The resolution is the interval between measuring the body and counting the dementia. Kivimäki and colleagues pooled individual-level data from 39 cohorts — 1,349,857 dementia-free participants, 6,894 incident cases — sorted by how long before diagnosis BMI had been recorded. Per 5 kg/m² higher BMI, the hazard ratio for dementia was 0.71 (95% CI 0.66–0.77) when BMI was measured within 10 years of diagnosis, 0.94 (0.89–0.99) at 10 to 20 years, and 1.16 (1.05–1.27) beyond 20 years. The sign flips as the interval lengthens, because two processes are superimposed: a real harmful effect of higher BMI, visible only over long follow-up, and a reverse-causation effect in which preclinical dementia causes weight loss and so makes higher weight look protective.
That prodromal weight loss has been timed. In the Indianapolis Dementia Project, 1,331 African American adults aged 65 and over were followed up to 12 years with repeated BMI measurement. BMI did not differ between those who developed dementia and those who did not at 12 or 9 years before diagnosis; at 6 years before, the incident-dementia group already had significantly lower BMI (p=0.03). The WHO guideline puts it plainly: the underweight–dementia association is likely explained at least in part by reverse causality — brain pathology causing weight loss before clinical onset.
Two consequences follow, both opposite to the obvious reading. A high BMI at seventy-eight is not evidence that weight protects the brain. And unexplained weight loss in an older adult is not an achievement — it is a finding, and it belongs in front of a doctor.
BMI is a crude instrument, and waist measurements add something
BMI cannot distinguish muscle from fat or say where the fat sits. In a second Kaiser cohort, 6,583 people had their sagittal abdominal diameter measured in 1964–1973 and were followed an average of 36 years, producing 1,049 dementia diagnoses. The highest quintile of abdominal diameter carried a hazard ratio of 2.72 (95% CI 2.33–3.33) against the lowest — attenuated but still 1.92 (1.58–2.35) once BMI entered the model, the signal that central fat carries information BMI does not. Obesity plus high abdominal diameter gave the highest risk, 3.60 (2.85–4.55).
One caveat gets dropped. The subgroup with a high abdominal diameter but a normal BMI had a hazard ratio of 1.89, confidence interval 0.98 to 3.81 — it crosses 1.0. The tempting conclusion, that central fat raises risk even at a normal BMI, is not what that study established. It is a direction, not a finding.
Cross-sectional imaging agrees: in 9,652 UK Biobank participants, higher BMI, waist-to-hip ratio and fat mass were each associated with lower grey matter volume, none with white matter.
What the genetics support, and what they do not
Mendelian randomisation uses inherited variants as a proxy for lifelong exposure, which makes it relatively resistant to the problem above. A 2026 analysis combining Copenhagen and UK cohorts with consortium data found that per standard deviation of genetically predicted BMI, the odds ratio for vascular-related dementia was 1.63 (95% CI 1.13–2.35) in pooled one-sample analyses, with two-sample methods giving 1.54 to 1.98. Systolic blood pressure mediated an estimated 18% of that effect and diastolic 25% — which is why blood pressure keeps reappearing, and why the Commission's factors overlap rather than stacking.
Read the limits. The headline outcome there was vascular-related dementia, not Alzheimer's disease. And an MR estimate describes a lifetime of higher BMI, not whether changing something at fifty-five changes an outcome at eighty. Genetics can say the exposure matters; not that the intervention works.
Does intentional weight loss improve cognition? We do not know
The literature thins badly here, and a company like ours has every incentive to overstate it. The most-cited positive result is a 2017 meta-analysis reporting that voluntary weight loss was associated with improved attention and memory. It contains 20 studies, only 7 randomised, 328 treated against 140 controls. The domains that improved differed by design — executive function in the longitudinal studies, language in the randomised ones — the pattern noise makes. Appraising that same review, WHO noted the interventions ran 8 to 48 weeks and that no data existed on incident mild cognitive impairment or dementia at all.
A 2023 meta-analysis in people with diabetes pooled 5 studies and 619 participants: standardised mean difference 0.50, 95% CI −0.09 to 1.08. That crosses zero: a null, and the authors called weight loss possibly neutral to cognitive function.
Then the one long trial. Look AHEAD randomised overweight and obese adults with type 2 diabetes to a decade of intensive lifestyle intervention versus diabetes support and education, and it did produce and sustain marked differences in weight and activity. Cognitive status was adjudicated in 3,802 participants at an average of 11.4 years: mild cognitive impairment 6.4% versus 6.6%, probable dementia 1.8% versus 1.8%, p=0.93. It was graded Class II evidence that such an intervention does not lower cognitive-impairment risk, with evidence (p=0.03) that the effect ran from benefit to harm as baseline BMI rose. A 2026 follow-up over 12 to 14 further years sharpened that: hazard ratios of 0.64 (0.46–0.89) at BMI 25–29, 0.98 (0.85–1.16) at 30–39 and 1.40 (1.01–1.93) at 40 or above, interaction p=0.004 — a subgroup analysis whose last interval only just clears 1.0, but not the direction anyone expected.
The observational case that midlife obesity raises risk is strong; the trial case that losing weight lowers it does not yet exist. Price them differently.
The route that is genuinely actionable: sleep apnoea
Here the chain has been shown within people, not across them. In the Wisconsin Sleep Cohort, 690 adults were assessed twice, four years apart. Relative to stable weight, a 10% weight gain predicted a 32% rise in the apnoea–hypopnoea index (95% CI 20–45) and a six-fold increase in the odds of developing moderate-to-severe sleep-disordered breathing (2.2–17.0); a 10% weight loss predicted a 26% fall in the index (18–34). Weight moves the airway, in both directions, at magnitudes people reach.
Untreated sleep apnoea then tracks with worse cognition: a 2026 meta-analysis of 15 studies and 740,901 people found it more prevalent among adults with cognitive impairment than without, odds ratio 1.57 (95% CI 1.31–1.88) — cross-sectional, so direction is unestablished. Across 17 randomised trials and 2,372 participants, CPAP improved daytime sleepiness (weighted mean difference −2.15, −2.96 to −1.33) and processing speed (0.25, 0.07 to 0.43). Nobody has shown it changes dementia incidence.
Sleep apnoea is common, underdiagnosed and worth treating on its own merits. The STOP-BANG questionnaire takes two minutes, home testing has real limits worth knowing first, and no supplement — ours included — does anything for an obstructed airway.
Physical activity has the better-graded evidence
The clearest view: two recommendations from the same WHO guideline, same panel, same method. For obesity: interventions for mid-life overweight and/or obesity may be offered to reduce the risk of cognitive decline and/or dementia — quality of evidence low to moderate, strength of recommendation conditional. For physical activity: physical activity should be recommended to adults with normal cognition to reduce the risk of cognitive decline — quality of evidence moderate, strength of recommendation strong.
The guideline's rationale notes that the apparent cognitive benefits of weight loss tended to travel with increases in physical activity. Activity is worth doing for reasons that do not depend on the scale moving, and our own comparison of exercise against supplements does not flatter us either.
Where we fit, which is nowhere
Nothing we sell affects body weight, and we are not going to imply otherwise. If your weight is something you want to change, that is a conversation for your GP; this article has deliberately given you no diet, no calorie target and no plan.
What remains is useful. The factor is on the Commission's list, and its evidence base is a midlife one. Per-factor attributable percentages are reported so inconsistently that quoting one for obesity misleads — a 2026 analysis found its weighted share ranged from 0.2% to 5.9% across 28 countries — so what the 45% headline does and does not mean is worth reading first, alongside the factor-by-factor breakdown. The same cluster drives stroke risk. And if what brought you here is that your memory feels different, read whether that is normal ageing or not and when it warrants a doctor rather than a purchase.
This article is for information only, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure or prevent any disease. It cannot assess your individual risk. Unexplained or unintentional weight loss at any age warrants medical assessment, and any change to body weight belongs in a conversation with a clinician who knows your history.
Sources: Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. 2015;3:431–436. doi:10.1016/S2213-8587(15)00033-9 · Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330:1360. doi:10.1136/bmj.38446.466238.E0 · Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011;12:e426–e437. doi:10.1111/j.1467-789X.2010.00825.x · Albanese E, Launer LJ, Egger M, et al. Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst). 2017;8:165–178. doi:10.1016/j.dadm.2017.05.007 · Kivimäki M, Luukkonen R, Batty GD, et al. Body mass index and risk of dementia: analysis of individual-level data from 1.3 million individuals. Alzheimers Dement. 2018;14:601–609. doi:10.1016/j.jalz.2017.09.016 · Gao S, Nguyen JT, Hendrie HC, et al. Accelerated weight loss and incident dementia in an elderly African-American cohort. J Am Geriatr Soc. 2011;59:18–25. doi:10.1111/j.1532-5415.2010.03169.x · Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology. 2008;71:1057–1064. doi:10.1212/01.wnl.0000306313.89165.ef · Hamer M, Batty GD. Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study. Neurology. 2019;92:e594–e600. doi:10.1212/WNL.0000000000006879 · Nordestgaard LT, Luo J, Emanuelsson F, et al. High body mass index as a causal risk factor for vascular-related dementia: a Mendelian randomization study. J Clin Endocrinol Metab. 2026;111:e1681–e1694. doi:10.1210/clinem/dgaf662 · Veronese N, Facchini S, Stubbs B, et al. Weight loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;72:87–94. doi:10.1016/j.neubiorev.2016.11.017 · Wang Y, Shi M, Li X. Effects of weight loss on cognitive function in patients with diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2023;200:110687. doi:10.1016/j.diabres.2023.110687 · Espeland MA, Luchsinger JA, Baker LD, et al. Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment. Neurology. 2017;88:2026–2035. doi:10.1212/WNL.0000000000003955 · Espeland MA, Neiberg RH, Rapp SR, et al. Does lifestyle intervention lower clinically significant cognitive impairment risk? Alzheimers Dement. 2026;22:e71668. doi:10.1002/alz.71668 · Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–3021. doi:10.1001/jama.284.23.3015 · Chu C, Gupta K, Saripella A, et al. The prevalence of obstructive sleep apnea in adults with versus without cognitive impairment: a systematic review and meta-analysis. Sleep Med Rev. 2026;88:102287. doi:10.1016/j.smrv.2026.102287 · Che L, Wang J, Wu R, Su R. Effect of continuous positive airway pressure on cognitive impairment associated with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials. Cranio. 2026;44:556–570. doi:10.1080/08869634.2025.2568806 · Burley CV, Sohrabi HR, Alshahrani M, et al. Country-specific modifiable dementia risk factors across the Western Pacific Region determined by population attributable fraction. Lancet Reg Health West Pac. 2026;69:101857. doi:10.1016/j.lanwpc.2026.101857 · World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: WHO; 2019. · Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572–628. doi:10.1016/S0140-6736(24)01296-0